Japanese
FALCO biosystems  
MENU
News & Topics
About FALCO biosystems
Corporate Data
Investor Relations
About this site
image
Clinical testing is a vital part of disease diagnosis and treatment decisions, as well as health checkups. Our company mission is to contribute to quality healthcare for all by efficiently supplying medical institutions with accurate test data. Since our company was established in 1962, we have broadened the scope of our business in line with advances in medical and testing technologies. At present, the FALCO Group is involved in genetic testing, clinical research and trials, research and development in clinical biochemistry, medical information technology, food sanitation and environmental health testing, and dispensing pharmacies, as well as our core business of clinical testing. Through its businesses the FALCO Group will continue to support health in body and spirit, for a rewarding future for all.
image Back Number
what's new
line
Aug.6,2010 Consolidated Financial Report for the Three Months Ended June 30,2010
Jul.20,2010 FALCO to Transfer Management Business to its Subsidiary by (Simple Absorption-type) Corporate Split
Jul.20,2010 Announcement Regarding Establishment of a Subsidiary
Jun.30,2010 Regarding Development of System Tool That Enables Test Acceptance through Other Makers’eChart
Jun.22,2010 Notice of Personnel Changes
Jun.14,2010 Announcement on the Release of the Newest OS Windows 7 Supported New Version of the eChart “@homeDr. (At home doctor)” Designed for Clinics
May.17,2010 Announcement of the Formulation of the Medium-Term Management Plan “plan2013”
May.7,2010 Consolidated Earnings Report For Fiscal Year Ended March 31, 2010
May.6,2010 Announcement of a Revision in the Earnings Forecast (Consolidated) for the Full Term for the Period Ended March 2010
Apr.30,2010 Announcement of a Revision in the Earnings Forecast (Consolidated and Non-Consolidated) for the Full Term for the Period Ended March 2010
Apr.6,2010 Notice of Conclusion of Exclusive Distribution Agreement with Saladax Biomedical for the 5-FU MYCARE Assay in Japan
Mar.15,2010 Announcement Concerning Organizational System and Personnel
Feb.15,2010 Announcement Concerning Organizational Structure of FALCO SD HOLDINGS Co., Ltd. and Changes of Representative Director and Group Officers
Jan.27,2010 Consolidated Earnings Report for the Three Months Ended December 20, 2009
(September 21, 2009-December 20, 2009)
Jan.25,2010 Announcement Regarding Appraisal Loss on Investment Securities for the First Quarter of the Period Ending March 2010
Dec.17,2009 Announcement Concerning the Passage of Approval at the Ordinary General Meeting of Shareholders for Agreements on an Absorption-Type Split and a Share Swap
Nov.17,2009 Announcement Concerning the Conclusion of a Commitment Line Agreement
Nov.5,2009 Consolidated Earnings Report For Fiscal Year Ended September 20, 2009
Nov.5,2009 Announcement Concerning Changes of Directors and Other Personnel
Nov.5,2009 Announcement Concerning a Change of Business Name and Accounting Term and Partial Changes to the Company’s Articl of Incorporation
Nov.5,2009 Announcement Concerning Entry into a Share Swap Agreement between FALCO biosystems Ltd. and SIMENO DRUG Co., Ltd. and Entry into an Agreement with FALCO Communications Ltd. on an Absorption-Type Split
Sep.28,2009 Announcement Concerning the Signing of the Basic Agreement for FALCO biosystems Ltd. to Implement Share Swap and Business Merger with SIMENO DRUG Co., Ltd. and the Conversion of FALCO biosystems Ltd. into a Pure Holding Company
Sep.4,2009 Changes in the Schedule, etc. of the Share Swap and Business Merger with SIMENO DRUG Co., Ltd. and Related Matters of Agreement
Jul.28, 2009 Consolidated Earnings Report for the Nine Months Ended June 20, 2009
Jul.23, 2009 Announcement of a Revision in the Earnings Forecast (Consolidated and Non-Consolidated) for the Full Term for the Period Ending September 2009
Apr.28,2009 Consolidated Earnings Report for Six Months Ended March 20, 2009
Apr.23,2009 Announcement of a Revision in the Earnings Forecast (Consolidated and Non-Consolidated) for the Six Months Ending March 20 and the Full Term for the Period Ending September 2009
Apr.23,2009 Announcement Regarding Appraisal Loss on Investment Securities for the 2nd Quarter of the Period Ending September 2009
Apr.10,2009 Notice of Acquisition of Treasury Stock and Its Completion
Mar.10,2009 Notice of Acquisition of Treasury Stock
Feb.16,2009 Notice of Decision Regarding Acquire Treasury Stock
Feb.4,2009 Results of Treasury Stock Acquisition on J-Net Market of the Osaka Securities Exchange
Feb.3,2009 Notice of Decision to Acquire Treasury Stock and Make "Treasury Stoc Acquisition on J-Net Market of the Osaka Securities Exchange"
Jan.30,2009 FALCO biosystems Ltd. to Implement Share Swap and Business Merger with SIMENO DRUG Co., Ltd; FALCO biosystems to Change into Pure Holding Company
Jan.28,2009 Consolidated Earnings Report for the Three Months Ended December 20, 2008
Jan.19,2009 Notice of a Merger between Consolidated Subsidiaries
Jan.19,2009 Notice of Personnel Changes
Jan.9,2009 Notice of Acquisition of Treasury Stock and Its Completion
Jan.9,2009 Announcement of the Posting of an Appraisal Loss on Investment Securities
Dec.8,2008 Notice of Acquisition of Treasury Stock
Nov.5,2008 Consolidated Earnings Report For Fiscal Year Ended September 20, 2008
Nov.5,2008 Announcement of the Retirement of an Auditor
Nov.5,2008 Notice of Decision Regarding Acquire Treasury Stock
Nov.4,2008 Announcement of a Revision of the Earnings Forecast
(Consolidated and Non-Consolidated)
Oct.29,2008 Announcement of the Posting of an Appraisal Loss on Investment Securities
Oct.15,2008 Release of research study result
Oct.1,2008 Notice of Conclusion of CYP2D6*4 Gene Patent Licensing Agreement with LGC
Sep.16,2008 Notice of Organizational and Personnel Changes
Sep.16,2008 Notice of a Merger between Consolidated Subsidiaries
Aug.11,2008 @homeDr. ("at-home doctor"), an electronic medical chart for use at clinics, released
Aug.5,2008 Notice of Acquisition of Treasury Stock and Its Completion
Jul.25,2008 Consolidated Earnings Report For the Nine Months Ended June 20, 2008
Jul.10,2008 Notice of Acquisition of Treasury Stock
Jun.10,2008 Notice of Acquisition of Treasury Stock
May.21,2008 Notice of Decision Regarding Acquire Treasury Stock
May.21,2008 Notice of Acquisition of Treasury Stock
May.8,2008 Consolidated Interim Earnings Report For Fiscal Year Ending September 20, 2008
May.8,2008 Notice of Acquisition of Treasury Stock
May.1,2008 Notice of Revisions to Forecasts for Interim and Full Fiscal Year
(Consolidated and Non-Consolidated Basis)
Apr.10,2008 Notice of Acquisition of Treasury Stock
Mar.31.2008 Commencement of ASP-based content services for ”Ethical Drug Information Retrieval”and ”Consultation Appointmen”
Mar.31.2008 Commencement of commissioned ”Gene-expression test for predicting postoperative recurrence of lung adenocarcinoma” based on the consignment contract with Oncomics, Co., Ltd.


Fast and Accurate Laboratories with Confidence.Copyright(C) FALCO biosystems Ltd. All Rights Reserved.